As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

For individuals diagnosed with schizophrenia, maintaining a daily medication routine can feel like an insurmountable challenge. The cognitive impairments associated with the disorder often interfere ...

Schizophrenia may be misdiagnosed as depression or bipolar disorder, which delays treatment and negatively impacts the prognosis, explained Megan Ehret, PharmD, MS, BCPP, of the University of Maryland ...

How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic lateral sclerosis (ALS), has now set its sights on using the pill to provide a ...

This post was co-authored by Shontae Cameron, and Robert T. Muller, Ph.D. The World Health Organization estimates that schizophrenia affects around 24 million people, or roughly 1 in 300 individuals ...

"About 10% of people with schizophrenia will engage in violence during their lifetimes, which is three to four times higher than the general population, but people with schizophrenia are more likely ...

To understand iclepertin's safety and efficacy, researchers pooled phase 3 trial data, focusing on cognition in CIAS patients.